Machina Capital S.A.S. Purchases 24,263 Shares of Colgate-Palmolive Company (NYSE:CL)

Machina Capital S.A.S. grew its holdings in shares of Colgate-Palmolive Company (NYSE:CL - Free Report) by 169.0% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 38,616 shares of the company's stock after buying an additional 24,263 shares during the quarter. Colgate-Palmolive accounts for approximately 1.1% of Machina Capital S.A.S.'s holdings, making the stock its 10th biggest holding. Machina Capital S.A.S.'s holdings in Colgate-Palmolive were worth $3,618,000 as of its most recent SEC filing.

Other institutional investors have also recently made changes to their positions in the company. Westend Capital Management LLC increased its holdings in Colgate-Palmolive by 111.1% during the 1st quarter. Westend Capital Management LLC now owns 266 shares of the company's stock worth $25,000 after purchasing an additional 140 shares during the period. Cornerstone Planning Group LLC raised its holdings in shares of Colgate-Palmolive by 1,913.3% in the first quarter. Cornerstone Planning Group LLC now owns 302 shares of the company's stock valued at $28,000 after acquiring an additional 287 shares in the last quarter. Vermillion Wealth Management Inc. purchased a new stake in Colgate-Palmolive in the fourth quarter worth about $31,000. Accredited Wealth Management LLC bought a new position in Colgate-Palmolive during the 4th quarter worth about $34,000. Finally, Bernard Wealth Management Corp. purchased a new position in Colgate-Palmolive during the 4th quarter valued at about $33,000. Institutional investors own 80.41% of the company's stock.

Colgate-Palmolive Trading Down 0.6%

Shares of CL stock traded down $0.52 during mid-day trading on Friday, reaching $87.93. The company's stock had a trading volume of 3,186,104 shares, compared to its average volume of 4,561,019. Colgate-Palmolive Company has a 12-month low of $85.32 and a 12-month high of $109.30. The firm has a market capitalization of $71.26 billion, a PE ratio of 24.84, a price-to-earnings-growth ratio of 4.53 and a beta of 0.37. The company has a quick ratio of 0.54, a current ratio of 0.85 and a debt-to-equity ratio of 8.96. The company's 50 day simple moving average is $90.24 and its 200-day simple moving average is $90.37.

Colgate-Palmolive (NYSE:CL - Get Free Report) last posted its earnings results on Friday, April 25th. The company reported $0.91 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.86 by $0.05. Colgate-Palmolive had a return on equity of 461.04% and a net margin of 14.52%. The business had revenue of $4.91 billion during the quarter, compared to analyst estimates of $4.92 billion. During the same quarter last year, the firm earned $0.86 earnings per share. The company's revenue for the quarter was down 3.0% compared to the same quarter last year. On average, research analysts predict that Colgate-Palmolive Company will post 3.75 EPS for the current fiscal year.

Colgate-Palmolive Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, August 15th. Shareholders of record on Friday, July 18th will be given a $0.52 dividend. The ex-dividend date is Friday, July 18th. This represents a $2.08 dividend on an annualized basis and a yield of 2.37%. Colgate-Palmolive's payout ratio is currently 58.76%.

Analyst Ratings Changes

CL has been the subject of a number of analyst reports. Piper Sandler decreased their price objective on Colgate-Palmolive from $108.00 to $107.00 and set an "overweight" rating for the company in a research note on Monday, March 31st. Wall Street Zen downgraded shares of Colgate-Palmolive from a "buy" rating to a "hold" rating in a research note on Wednesday, May 7th. Barclays raised their price objective on Colgate-Palmolive from $86.00 to $87.00 and gave the stock an "equal weight" rating in a research report on Tuesday, July 15th. Wells Fargo & Company raised their price target on Colgate-Palmolive from $83.00 to $88.00 and gave the stock an "underweight" rating in a report on Wednesday, April 2nd. Finally, UBS Group cut their price objective on shares of Colgate-Palmolive from $109.00 to $106.00 and set a "buy" rating on the stock in a report on Thursday, July 17th. One investment analyst has rated the stock with a sell rating, seven have given a hold rating and seven have assigned a buy rating to the company. According to data from MarketBeat.com, Colgate-Palmolive has a consensus rating of "Hold" and a consensus price target of $100.77.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.